UGenome
  • Home
    • 1-minute UGenome overview
  • About
    • UGenome in the News
    • About
    • Contact
    • Team
    • Advisors
    • Partners & Collaborators
    • UGenome’s Mission, Vision, Values
    • UGenome Policies October 2025
    • Investors
  • Genomic Software
  • Bioinformatics
    • Bioinformatics Services
    • Bioinformatics Case Studies
  • Medication Response Solutions
    • UGenome’s PGx Case Studies
    • Emerging Trends
    • Rare Disease & Women’s Health Resources
    • Dictionary
Select Page

PGx Case study: CYP2D6 and neuropathic pain and SNRI

by Brooks | Jan 3, 2025 | PGx Case Studies

UGenome and Pharmacogenomic Solutions and Personalized Medication. Contact us today! LP is a 63-year-old male who presents to the clinic for follow up of his neuropathic pain. About 6 weeks ago, LP felt his diabetic peripheral neuropathy (DPN) was getting worse. He...
Next Entries »

Recent Posts

  • Could Genetic Biomarkers Transform Kidney Disease Treatment?  
  • How Do National Genome Projects Advance the Power of Pharmacogenomics? 
  • How can Pharmacogenomics Protect Older Adults from the Risks of Polypharmacy?
  • Can Genetic Insights Refine Arrhythmia Treatment?
  • Pharmacogenomics, Nutrigenomics, and Longevity

Recent Comments

No comments to show.

UGenome Social Media

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

Sign up for UGenome's Newsletter on LinkedIn!

 

Click Here
Website built by The Free Website Guys 🚀
  • Follow
  • Follow